Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 17, 2024
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational studyHironori Fujii, Masami Tsuchiya, Daichi Watanabe, et al.Frontiers in Immunology|March 20, 2025
Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost studyMasaya Fujitani, Xiuyuan Lu, Ryo Shinnakasu, et al.Intensive Care Medicine Experimental|January 28, 2024
Recombinant antithrombin attenuates acute kidney injury associated with rhabdomyolysis: an in vivo animal studyTomotaka Miura, Tomoki Okuda, Kodai Suzuki, et al.Journal of Cancer|October 2, 2023
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 StudyHirotoshi Iihara, Mototsugu Shimokawa, Hiroko Bando, et al.The American Journal of Pathology|June 11, 2021
Recombinant Antithrombin Attenuates Acute Respiratory Distress Syndrome in Experimental EndotoxemiaHaruka Okamoto, Isamu Muraki, Hideshi Okada, et al.International Journal of Clinical and Experimental Pathology|January 11, 2021
Ultrastructural alteration of pulmonary tissue under conditions of high oxygen concentrationHirohisa Yano, Ayumi Kuroda, Hideshi Okada, et al.Shock (Augusta, Ga.)|November 26, 2019
Neutrophil Elastase Inhibition Ameliorates Endotoxin-induced Myocardial Injury Accompanying Degradation of Cardiac Capillary GlycocalyxTetsuya Fukuta, Hideshi Okada, Genzou Takemura, et al.Heliyon|November 10, 2022
Recombinant thrombomodulin may protect cardiac capillary endothelial glycocalyx through promoting Glypican-1 expression under experimental endotoxemiaYoshinori Kakino, Tomoaki Doi, Hideshi Okada, et al.Journal of Clinical Medicine|August 30, 2019
Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical ExaminationKazumasa Oda, Hideshi Okada, Akio Suzuki, et al.Journal of Cancer|February 19, 2024
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002)Senri Yamamoto, Masami Tsuchiya, Hirotoshi Iihara, et al.Pageof 21